343 related articles for article (PubMed ID: 26180996)
1. Effect of coronary artery disease severity and revascularization completeness on 2-year clinical outcomes in patients undergoing transcatether aortic valve replacement.
Witberg G; Lavi I; Harari E; Shohat T; Orvin K; Codner P; Vaknin-Assa H; Assali A; Kornowski R
Coron Artery Dis; 2015 Nov; 26(7):573-82. PubMed ID: 26180996
[TBL] [Abstract][Full Text] [Related]
2. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation.
Stefanini GG; Stortecky S; Cao D; Rat-Wirtzler J; O'Sullivan CJ; Gloekler S; Buellesfeld L; Khattab AA; Nietlispach F; Pilgrim T; Huber C; Carrel T; Meier B; Jüni P; Wenaweser P; Windecker S
Eur Heart J; 2014 Oct; 35(37):2530-40. PubMed ID: 24682843
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality.
O'Sullivan CJ; Englberger L; Hosek N; Heg D; Cao D; Stefanini GG; Stortecky S; Gloekler S; Spitzer E; Tüller D; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Carrel T; Meier B; Windecker S; Wenaweser P
JACC Cardiovasc Interv; 2015 Apr; 8(5):704-17. PubMed ID: 25946444
[TBL] [Abstract][Full Text] [Related]
4. Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement.
Paradis JM; White JM; Généreux P; Urena M; Doshi D; Nazif T; Hahn R; George I; Khalique O; Harjai K; Lasalle L; Labbé BM; DeLarochellière R; Doyle D; Dumont É; Mohammadi S; Leon MB; Rodés-Cabau J; Kodali S
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219920
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Effects of Coronary Disease Severity and Completeness of Revascularization on Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement.
Witberg G; Regev E; Chen S; Assali A; Barbash IM; Planer D; Vaknin-Assa H; Guetta V; Vukasinovic V; Orvin K; Danenberg HD; Segev A; Kornowski R
JACC Cardiovasc Interv; 2017 Jul; 10(14):1428-1435. PubMed ID: 28728656
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Coronary Lesion Complexity and Preprocedural Revascularization on 5-Year Outcomes After TAVR.
Minten L; Wissels P; McCutcheon K; Bennett J; Adriaenssens T; Desmet W; Sinnaeve P; Verbrugghe P; Jacobs S; Guler I; Dubois C
JACC Cardiovasc Interv; 2022 Aug; 15(16):1611-1620. PubMed ID: 35981834
[TBL] [Abstract][Full Text] [Related]
7. Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
Huczek Z; Zbroński K; Grodecki K; Scisło P; Rymuza B; Kochman J; Dąbrowski M; Witkowski A; Wojakowski W; Parma R; Ochała A; Grygier M; Olasińska-Wiśniewska A; Araszkiewicz A; Jagielak D; Ciećwierz D; Puchta D; Paczwa K; Filipiak KJ; Wilimski R; Zembala M; Opolski G
Catheter Cardiovasc Interv; 2018 Jan; 91(1):115-123. PubMed ID: 28843025
[TBL] [Abstract][Full Text] [Related]
8. Impact of extent of coronary artery disease and percutaneous revascularization assessed by the SYNTAX score on outcomes following transcatheter aortic valve replacement.
Stephan T; Thoma E; Rattka M; Felbel D; Buckert D; Rottbauer W; Gonska B; Markovic S
BMC Cardiovasc Disord; 2021 Nov; 21(1):568. PubMed ID: 34847875
[TBL] [Abstract][Full Text] [Related]
9. Impact of Coronary Artery Disease on Postoperative Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR): Is Preoperative Coronary Revascularization Necessary?
Chauhan D; Thawabi M; Haik N; Haik BJ; Chen C; Cohen M; Russo M
J Invasive Cardiol; 2016 Dec; 28(12):E179-E184. PubMed ID: 27922809
[TBL] [Abstract][Full Text] [Related]
10. Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation.
Shamekhi J; Stundl A; Weber M; Mellert F; Welz A; Grube E; Nickenig G; Werner N; Sinning JM
Int J Cardiol; 2017 Oct; 245():215-221. PubMed ID: 28789844
[TBL] [Abstract][Full Text] [Related]
11. The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry.
Park KW; Kang J; Kang SH; Ahn HS; Kang HJ; Koo BK; Chae IH; Youn TJ; Oh BH; Park YB; Kandzari D; Kim HS
Am Heart J; 2014 Mar; 167(3):384-392.e5. PubMed ID: 24576524
[TBL] [Abstract][Full Text] [Related]
12. Impact of Coronary Revascularization in Patients Who Underwent Transcatheter Aortic Valve Implantation.
López Otero D; Ávila-Carrillo A; González Ferreiro R; Cid Menéndez A; Iglesias Álvarez D; Álvarez Rodríguez L; Antúnez Muiños P; Álvarez BC; Sanmartín Pena XC; Gómez Pérez F; Diéguez AR; Cruz-González I; Trillo Nouche R; González-Juanatey JR
Am J Cardiol; 2019 Mar; 123(6):948-955. PubMed ID: 30598242
[TBL] [Abstract][Full Text] [Related]
13. Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry.
Chakravarty T; Sharma R; Abramowitz Y; Kapadia S; Latib A; Jilaihawi H; Poddar KL; Giustino G; Ribeiro HB; Tchetche D; Monteil B; Testa L; Tarantini G; Facchin M; Lefèvre T; Lindman BR; Hariri B; Patel J; Takahashi N; Matar G; Mirocha J; Cheng W; Tuzcu ME; Sievert H; Rodés-Cabau J; Colombo A; Finkelstein A; Fajadet J; Makkar RR
J Am Coll Cardiol; 2016 Mar; 67(8):951-960. PubMed ID: 26916485
[TBL] [Abstract][Full Text] [Related]
14. Impact of Coronary Artery Revascularization Completeness on Outcomes of Patients With Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis of Studies Using the Residual SYNTAX Score (Synergy Between PCI With Taxus and Cardiac Surgery).
Witberg G; Zusman O; Codner P; Assali A; Kornowski R
Circ Cardiovasc Interv; 2018 Mar; 11(3):e006000. PubMed ID: 29870384
[TBL] [Abstract][Full Text] [Related]
15. SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial.
Girasis C; Garg S; Räber L; Sarno G; Morel MA; Garcia-Garcia HM; Lüscher TF; Serruys PW; Windecker S
Eur Heart J; 2011 Dec; 32(24):3115-27. PubMed ID: 21951630
[TBL] [Abstract][Full Text] [Related]
16. Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registry.
Puymirat E; Didier R; Eltchaninoff H; Lung B; Collet JP; Himbert D; Durand E; Leguerrier A; Leprince P; Fajadet J; Teiger E; Chevreul K; Lièvre M; Tchetché D; Leclercq F; Chassaing S; Le Breton H; Donzeau-Gouge P; Lefèvre T; Carrié D; Gillard M; Blanchard D
Clin Cardiol; 2017 Dec; 40(12):1316-1322. PubMed ID: 29247516
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approach†.
Penkalla A; Pasic M; Drews T; Buz S; Dreysse S; Kukucka M; Mladenow A; Hetzer R; Unbehaun A
Eur J Cardiothorac Surg; 2015 Jun; 47(6):1083-9. PubMed ID: 25217500
[TBL] [Abstract][Full Text] [Related]
18. Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
Millan-Iturbe O; Sawaya FJ; Lønborg J; Chow DHF; Bieliauskas G; Engstrøm T; Søndergaard L; De Backer O
Catheter Cardiovasc Interv; 2018 Oct; 92(4):818-826. PubMed ID: 29214718
[TBL] [Abstract][Full Text] [Related]
19. Concomitant percutaneous coronary intervention and transcatheter aortic valve replacement: safe and feasible replacement alternative approaches in high-risk patients with severe aortic stenosis and coronary artery disease.
Salhab KF; Al Kindi AH; Lane JH; Knudson KE; Kapadia S; Roselli EE; Tuzcu ME; Svensson LG
J Card Surg; 2013 Sep; 28(5):481-3. PubMed ID: 23869423
[TBL] [Abstract][Full Text] [Related]
20. Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacement.
Li J; Patel SM; Nadeem F; Thakker P; Al-Kindi S; Thomas R; Makani A; Hornick JM; Patel T; Lipinski J; Ichibori Y; Davis A; Markowitz AH; Bezerra HG; Simon DI; Costa MA; Kalra A; Attizzani GF
Catheter Cardiovasc Interv; 2019 Feb; 93(3):545-552. PubMed ID: 30312990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
